Advaxis, Inc. : Advaxis Reports Survival and New Analysis for ADXS-HPV in … – 4-traders (press release)

Advaxis, Inc. : Advaxis Reports Survival and New Analysis for ADXS-HPV in
4-traders (press release)
Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today final 12 month overall survival and additional data from Lm-LLO-E7-15, a randomized Phase 2 study

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *